-
公开(公告)号:US20110098257A1
公开(公告)日:2011-04-28
申请号:US12981008
申请日:2010-12-29
申请人: JOHN L. WALLACE , GIUSEPPE CIRINO , GIUSEPPE CALIENDO , ANNA SPARATORE , VINCENZO SANTAGADA , STEFANO FIORUCCI
发明人: JOHN L. WALLACE , GIUSEPPE CIRINO , GIUSEPPE CALIENDO , ANNA SPARATORE , VINCENZO SANTAGADA , STEFANO FIORUCCI
IPC分类号: A61K31/625 , A61P35/00 , A61P29/00 , A61P1/04
CPC分类号: C07C323/59 , C07C323/60 , C07C327/42 , C07C327/48 , C07D339/04 , C07F9/3895 , C07F9/65785
摘要: The present invention provides new derivatives of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal diseases such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) and for the prevention/treatment of colon cancer. More particularly, these derivatives comprise a hydrogen sulfide releasing moiety linked via an azo, an ester, an anhydride, a thioester or an amide linkage to a molecule of 4- or 5-aminosalicylic acid. Furthermore, the present invention provides a process for preparing these compounds and their use for treating IBD and IBS and the prevention/treatment of colon cancer.
摘要翻译: 本发明提供4-或5-氨基水杨酸的新衍生物和含有这些4-或5-氨基水杨酸衍生物作为活性成分的药物组合物,其可用于治疗肠疾病如炎性肠病(IBD)和 肠易激综合征(IBS)和预防/治疗结肠癌。 更具体地说,这些衍生物包含通过偶氮,酯,酸酐,硫酯或酰胺键与4-或5-氨基水杨酸分子连接的硫化氢释放部分。 此外,本发明提供了制备这些化合物的方法及其用于治疗IBD和IBS以及预防/治疗结肠癌的用途。
-
公开(公告)号:US20110130368A1
公开(公告)日:2011-06-02
申请号:US12980985
申请日:2010-12-29
申请人: JOHN L. WALLACE , VINCENZO SANTAGADA , STEFANO FIORUCCI , GIUSEPPE CIRINO , GIUSEPPE CALIENDO , ANNA SPARATORE
发明人: JOHN L. WALLACE , VINCENZO SANTAGADA , STEFANO FIORUCCI , GIUSEPPE CIRINO , GIUSEPPE CALIENDO , ANNA SPARATORE
IPC分类号: A61K31/625 , A61P1/00 , A61P1/04 , A61P35/00 , A61K31/655
CPC分类号: C07C323/59 , C07C323/60 , C07C327/42 , C07C327/48 , C07D339/04 , C07F9/3895 , C07F9/65785
摘要: The present invention provides new derivatives of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal diseases such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) and for the prevention/treatment of colon cancer. More particularly, these derivatives comprise a hydrogen sulfide releasing moiety linked via an azo, an ester, an anhydride, a thioester or an amide linkage to a molecule of 4- or 5-aminosalicylic acid. Furthermore, the present invention provides a process for preparing these compounds and their use for treating IBD and IBS and the prevention/treatment of colon cancer.
-